Tetrahydrocannabinol (THC) Research Dashboard
Double-blind human trials
Clinical human trials
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 609 studies associated with Tetrahydrocannabinol (THC).
Here is a small sampling of Tetrahydrocannabinol (THC) studies by title:
- Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population
- Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
- Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury
- Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials
- Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
Components of the Tetrahydrocannabinol (THC) Research Dashboard
- Top medical conditions associated with Tetrahydrocannabinol (THC)
- Proven effects in clinical trials for Tetrahydrocannabinol (THC)
- Receptors associated with Tetrahydrocannabinol (THC)
- Individual study details for Tetrahydrocannabinol (THC)
Ready to become a subscriber? Go to our PRICING page.
Members can filter by the following criteria:
- Study Type
- Organ Systems
- Study Result
- Year of Publication
Overview - Tetrahydrocannabinol (THC)
Description of Tetrahydrocannabinol (THC)
The plant-based (phytocannabinoid) Delta-9-Tetrahydrocannabinol (THC) was discovered in 1964 and by 2016 thirty-one distinct members had been identified. THC is primarily (but not exclusively) responsible for many of positive and negative mind-altering effects associated with the herb. And, of course, THC is the most studied of all cannabis' individual parts. THC is exclusive to cannabis, but it is also produced synthetically.
Tetrahydrocannabinol (THC) Properties and Effects
THC is a multi-target molecule. Researchers have described more than 50 different pharmacological targets and effects of Delta 9-THC including analgesia, immunomodulation, bronchiodilation, relaxant (anti-stress).
Tetrahydrocannabinol (THC) Receptor Binding
Moderate affinity for CB1 (Mean Ki 25nM). Moderate affinity for CB2 (Mean Ki 35nM)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.